Is criticism by Keith Olbermann and others on the left really making investors sick about UnitedHealth‘s stock?
MarketWatch reports that one analyst says yes, maybe. Les Funtleyder of Miller Tabak tells the website that “profit-over-people” accusations in the media might be to blame for the company’s stock drop.
Or, there’s a considerably less exciting explanation: It “may be for no real reason other than sector rotation.”
UnitedHealth’s stock was down about 3 percent today, slightly more than competitors Cigna and Humana.